Por: WPLG Local 10 Health October 14, 2022
Kendall, Fla. – A South Florida based study is set to investigate a potential treatment approach for Alzheimer’s disease.Neurosurgeon Dr. Michael McDermott and his team at Baptist Health Miami Neuroscience Institute are using low-intensity focused ultrasound therapy to target the tau protein in the brains of Alzheimer’s patients.“And the idea is that that low-frequency ultrasound along with an intravenous microbubble agent will disrupt... + full article
Fox Business USA Business September 28, 2022
Dr. Stephen O'Brien, chief medical officer of Mediflix, shares how his streaming platform is trailblazing access to medical information for everyone. Shares of Biogen surged Wednesday's following news that its drug lecanemab showed promising signs of potentially... + más
Biogen shares rally as Alzheimer's drug results show promise | CBS News
Alzheimer's drug shows promise in early results of study | WPLG Local 10
CNN USA Health September 28, 2022
CNN — A monoclonal antibody treatment for Alzheimer’s disease called lecanemab slows the progression of cognitive decline by 27% compared with a placebo, drugmakers Biogen and Eisai said Tuesday. The drug, tested in a Phase 3 global clinical trial, also met all secondary... + más
New test can detect plaques early in the disease: Alzheimer's Q&A | The Advocate
Experimental Alzheimer’s drug slows cognitive decline in trial, firms say | Portland Press Herald
Newsweek USA Health September 24, 2022
The Alzheimer's Association defines Alzheimer's as a brain disease that causes a slow decline in memory, thinking and reasoning skills. Dementia refers to the symptoms of Alzheimer's that can worsen over time.They predict that by 2050, the number of people aged 65... + más
COVID-19 in seniors linked to increased Alzheimer’s risk, study finds | Portland Press Herald
There's a growing dementia crisis in the veteran community: Alzheimer's Q&A | The Advocate
Portland Press Herald USA Health September 24, 2022
A study using the electronic health records of more than 6 million Americans over age 65 found that those who had COVID-19 ran a greater risk of receiving a new diagnosis of Alzheimer’s disease within a year. The study, led by researchers at Case Western Reserve University... + más
How To Spot The Early Signs Of Alzheimer's | Newsweek
The Advocate USA Health September 17, 2022
Are U.S. veterans more at risk for Alzheimer’s or other dementias?The U.S. is in the midst of a dramatic rise in the number of veterans with Alzheimer’s disease and other dementias, and many of these new cases are directly attributable to military service.According to a 2017... + más
Stroke can lead to vascular dementia: Alzheimer's Q&A | The Advocate
Alzheimer's Q&A: Let go of negative thoughts | The Advocate
Is sildenafil being considered as a potential treatment for Alzheimer’s disease?Sildenafil could potentially be used as a treatment for Alzheimer’s disease, according to findings recently published in Nature Aging by Feixong Cheng, of the Cleveland Clinic.Per MedlinePlus, an... + más
US warns monkeypox could mutate to resist antiviral drug | ABC News
How do you assess the risk of Alzheimer’s disease?Alzheimer’s disease is the only disease in the top 10 causes of death in the United States that cannot be prevented, slowed, or cured. It is not fully understood what causes the disease, but probable causes could be linked to... + más
Here's how to protect patients from scammers: Alzheimer's Q&A | The Advocate
About iurex | Privacy Policy | Disclaimer |